These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38877551)

  • 1. Effect of different treatment modalities on the prognosis of stage IV epithelial ovarian cancer: analysis of the SEER database.
    Zhang S; Zhang H; Jia N; Suo S; Guo J
    BMC Womens Health; 2024 Jun; 24(1):345. PubMed ID: 38877551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    Chen Q; Wang S; Lang JH
    Arch Gynecol Obstet; 2021 Aug; 304(2):521-529. PubMed ID: 33543331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer outcomes: Predictors of early death.
    Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
    Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.
    Rauh-Hain JA; Melamed A; Wright A; Gockley A; Clemmer JT; Schorge JO; Del Carmen MG; Keating NL
    JAMA Oncol; 2017 Jan; 3(1):76-82. PubMed ID: 27892998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological parameters and survival of invasive epithelial ovarian cancer by histotype and disease stage.
    Lan A; Yang G
    Future Oncol; 2019 Jun; 15(17):2029-2039. PubMed ID: 31140868
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
    Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
    Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms for predicting overall survival and cancer-specific survival of endometrioid ovarian carcinoma: A retrospective cohort study from the SEER database.
    Wang D; Ran X; He Y; Zhu L; Deng Y
    Int J Gynaecol Obstet; 2024 Apr; 165(1):194-202. PubMed ID: 38009672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
    Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
    Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study.
    Zijlstra M; Timmermans M; Fransen H; van der Aa M; Reyners A; Raijmakers N; van de Poll-Franse L
    Int J Gynecol Cancer; 2019 Jul; 29(6):1032-1037. PubMed ID: 31263022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival trajectories among women with epithelial ovarian cancer.
    Peres LC; Sinha S; Townsend MK; Fridley BL; Karlan BY; Lutgendorf SK; Shinn E; Sood AK; Tworoger SS
    Gynecol Oncol; 2020 Feb; 156(2):459-466. PubMed ID: 31839342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
    Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy.
    Zhao L; Yu P; Zhang L
    Cancer Med; 2021 Jul; 10(13):4344-4355. PubMed ID: 34057318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer.
    Yoshihara M; Emoto R; Kitami K; Iyoshi S; Uno K; Mogi K; Tano S; Yoshikawa N; Matsui S; Kajiyama H
    Sci Rep; 2021 Jul; 11(1):15154. PubMed ID: 34312408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
    Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
    BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study.
    Manzanedo I; Pereira F; Serrano Á; Pérez-Viejo E; Martínez-Torres B; Carrión L; Calzas J
    Clin Transl Oncol; 2019 Oct; 21(10):1357-1363. PubMed ID: 30788835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.